Q4e: EBITDA of NOK 17.9m Margins set to rise in '23e on lower e-com investments '23e adj.
Redeye endorses that NeoDynamics partners with Uniphar for US distribution and logistics.
Stronger than expected sales but weak EBIT FDA's observations in the US being addressed Conference c...
DT’s Q4 and 22 EBIT saw an expected decrease. Group topline however grew nicely and soft Q4 profitab...
CapMan reported Q4 EBIT of 7.5m, 26% below Refinitiv consensus.
Redeye comments on Evolution’s Q4-results which came in slightly above our expectations.
Redeye comments Better Collective’s announcement that it has acquired a position of 5% in Catena Med...
Redeye states that Fram Skandinavien Q4 ’22 report was weaker than expected, but Carmudi beat our es...
Sales -3% vs. ABGSCe Adj. EBITDA -13% vs. ABGSCe Solid working capital management Q4 report The rep...
Hansa's Q4 is slightly below our and the market's sales expectations and slightly better in terms of...
Redeye comments on Sivers Q4'22 report which showed slightly better sales and EBITDA compared to our...
This morning, Vow announced that the company has received orders for three Safesteril food safety sy...
CapMan's net sales in Q4 amounted to EUR 19.7m, in line with our estimates and consensus (EUR 19.
Redeye retains its positive view on Lagercrantz following a solid Q3 report with 10% organic growth ...
Redeye updates its estimates and valuation following Vitec releasing its Q4 2022 report.
Q4 report due on Tuesday, February 7 Looking ahead to 2023 P/NAV 0.
Q4e adj. EBITA breakeven and 14% org. growth Limited '23e-'24e adj.
Redeye updates our outlook after Q4 2022 XVIVO. The result confirms that the key value drivers are o...
Redeye comments on Adverty's Q4 2022 report which beat our expectations across all levels.
Last night, the company presented a palette of one-time costs negatively impacting the Q4 figures.
